The U.S. Nuclear Regulatory Commission (NRC) is asking for comments on its proposed revision to a guidance document provided to patients receiving radioactive material.
The proposed revision (Revision 1) applies to the guide: “Release of Patients Administered Radioactive Material,” according to a release from the Society of Nuclear Medicine and Molecular Imaging (SNMMI). It would provide licensees with more information to give to patients.
Included in the proposed revision is:
- Specific safety information to offer patient before and after they have received radioactive material for an exam
- A new section on “Death of a Patient Following Radiopharmaceutical or Implants Administration”
- An updated table for “Dosages of Radiopharmaceuticals That Require Instructions and Records When Administered to Patients Who Are Breastfeeding an Infant or Child,”
- Detailed information about record-keeping
“NRC regulatory guidance documents, such as this one, describe enforcement methods used by regulators and provide licensees with implementation guidance beyond regulations,” the SNMMI release read.
Comments must be submitted by Aug. 26. Read the full proposal here.